683 CAPITAL MANAGEMENT, LLC – Syndax Pharmaceuticals, Inc. Transaction History
683 CAPITAL MANAGEMENT, LLC portfolio value:
$27.15M
portfolio value
683 CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+24.90%
quarter
Syndax Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -28.56% | -451.65K shares | -3.27M | $24.03 | 1.13M |
| Q2 2022 | share | 0.00% | 0 shares | 2.94M | $19.24 | 1.58M | |
| Q1 2022 | share | Increase | +13.34% | 186.16K shares | -3.05M | $17.38 | 1.58M |
| Q4 2021 | share | Increase | +22.85% | 259.59K shares | 8.84M | $21.78 | 1.39M |
| Q3 2021 | share | Increase | +4.60% | 50K shares | 3.06M | $19.11 | 1.13M |
| Q2 2021 | share | Increase | +30.05% | 250.9K shares | -26K | $17.17 | 1.08M |
| Q1 2021 | share | Decrease | -15.52% | -153.40K shares | -3.31M | $22.36 | 835K |
| Q4 2020 | share | Increase | +19.32% | 160.03K shares | 9.75M | $22.24 | 988.40K |
| Q3 2020 | share | Decrease | -18.50% | -188K shares | -2.83M | $14.76 | 828.37K |
| Q2 2020 | share | Increase | +8.93% | 83.33K shares | 4.82M | $14.82 | 1.01M |
| Q1 2020 | share | Increase | +0.87% | 8.03K shares | 2.11M | $10.97 | 933.03K |
| Q4 2019 | share | Decrease | -21.05% | -246.64K shares | -630K | $8.78 | 925K |
| Q3 2019 | share | Decrease | -27.50% | -444.30K shares | -6.29M | $7.47 | 1.17M |
| Q2 2019 | share | Increase | +1.10% | 17.59K shares | 6.65M | $9.31 | 1.61M |
| Q1 2019 | share | Increase | +19.03% | 255.51K shares | 2.41M | $5.25 | 1.59M |
| Q4 2018 | share | Increase | +157.74% | 821.83K shares | 1.76M | $4.45 | 1.34M |
| Q3 2018 | share | Increase | +38.93% | 146K shares | 1.57M | $8.08 | 521K |
| Q2 2018 | share | Increase | +32.40% | 91.77K shares | -1.39M | $7.02 | 375K |
| Q1 2018 | share | Increase | 0.00% | 283.23K shares | 4.03M | $14.23 | 283.23K |